Correlation Between Arcus Biosciences and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Protagonist Therapeutics, you can compare the effects of market volatilities on Arcus Biosciences and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Protagonist Therapeutics.
Diversification Opportunities for Arcus Biosciences and Protagonist Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Arcus and Protagonist is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Protagonist Therapeutics
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 1.31 times more return on investment than Protagonist Therapeutics. However, Arcus Biosciences is 1.31 times more volatile than Protagonist Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 1,456 in Arcus Biosciences on September 25, 2024 and sell it today you would earn a total of 135.00 from holding Arcus Biosciences or generate 9.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Arcus Biosciences vs. Protagonist Therapeutics
Performance |
Timeline |
Arcus Biosciences |
Protagonist Therapeutics |
Arcus Biosciences and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcus Biosciences and Protagonist Therapeutics
The main advantage of trading using opposite Arcus Biosciences and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.Arcus Biosciences vs. Fate Therapeutics | Arcus Biosciences vs. Caribou Biosciences | Arcus Biosciences vs. Karyopharm Therapeutics | Arcus Biosciences vs. X4 Pharmaceuticals |
Protagonist Therapeutics vs. Fate Therapeutics | Protagonist Therapeutics vs. Caribou Biosciences | Protagonist Therapeutics vs. Karyopharm Therapeutics | Protagonist Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |